呼吸照护设备市场－全球产业规模、份额、趋势、机会、预测：按产品、最终用户、地区和竞争对手划分，2021-2031年

全球呼吸照护设备市场预计将从 2025 年的 189.2 亿美元大幅成长至 2031 年的 310.7 亿美元，复合年增长率为 8.62%。

此领域涵盖用于诊断、监测和治疗心肺疾病的各种医疗设备，其增长主要受气喘和慢性阻塞性肺病（COPD）等慢性疾病全球发病率上升的驱动。美国肺臟协会在2024年的报告中强调了环境因素的影响，指出美国约有1.31亿人居住在空气污染严重的地区，这种情况会加剧肺部健康问题，并持续增加对补充氧气和支气管卫生用品的需求。

儘管有这些正面迹象，但由于购置先进的呼吸器和监测设备成本高昂，市场仍面临许多障碍。尤其是在开发中国家，医疗体系的财政限制往往阻碍了这些关键设备的采购，导致病患获得必要治疗的机会有限。此外，家庭呼吸服务缺乏统一的报销机制，为医疗服务提供者和患者都带来了经济上的不确定性，这可能会减缓价格敏感地区新治疗方法的普及。

市场驱动因素

全球慢性及传染性呼吸系统疾病盛行率的激增是呼吸照护设备市场的主要驱动力。由于污染和空气传播病原体导致的肺功能损害在全球范围内不断加剧，人们对可靠的诊断和治疗性介入的需求日益增长，尤其对于需要长期管理的疾病。日益加重的疾病负担迫使医疗系统增加呼吸道管理和氧气疗法设备的储备，以应对需要严重监护的患者数量不断增加的情况。世界卫生组织（世卫组织）发布的《2024年全球结核病报告》进一步印证了这项需求，报告估计，2023年全球将有1,080万人罹患结核病。

同时，对远端监测和家庭呼吸护理的需求显着增长，从根本上改变了服务的提供方式。病患和医疗服务提供者正着眼于智慧型便携设备，以便在传统医院环境之外提供持续护理，旨在降低再入院率并提高生活品质。这种向住宅护理的转变也体现在主要行业参与者的财务表现中。 Fisher & Paykel Healthcare 报告称，其家庭护理产品系列2024 年的收入增长了 18%，ResMed 也公布了季度收入增长 9%。这显示各企业正在持续投资于先进的住宅呼吸照护生态系统。

市场挑战

全球呼吸照护设备市场成长的主要障碍之一是先进监测和通气技术的实施成本高昂。这一经济障碍严重限制了必要医疗设备的采购能力，尤其是在医疗基础设施往往资金不足的开发中国家。因此，无法购买这些关键设备限制了患者获得必要治疗的机会，并减缓了价格敏感地区创新治疗方案的推广应用。

此外，呼吸系统疾病带来的巨大经济负担进一步加剧了医疗预算的压力，并耗尽了昂贵设备升级的投资资源。欧洲呼吸学会的报告显示，到2024年，欧盟与肺部健康相关的年度社会成本将达到4,220亿欧元，这笔巨额财政负担给医疗服务提供者带来了不确定性，并使报销机制复杂化。因此，由于医疗系统难以平衡不断上涨的疾病管理成本与对先进技术解决方案的需求，关键地区的市场扩张往往停滞不前。

市场趋势

利用人工智慧 (AI) 和机器学习的预测性诊断技术正在呼吸系统领域迅速发展。这一趋势的驱动力在于对肺部影像和呼吸生物特征分析自动化技术的大规模资本投入。目前，一些复杂的演算法正在研发中，这些演算法能够比人工方法更准确地检测早期恶性肿瘤和肺结核，从而赢得了投资者对其改善临床疗效资金筹措的强烈信心。例如，Qure.ai 在 2024 年 9 月完成了 6,500 万美元的 D 轮资金筹措，加速了其人工智慧驱动的肺部健康解决方案在美国市场的扩张。这凸显了业界对自动化诊断能力的重视。

同时，物联网和智慧连接技术在呼吸设备中的应用正在改变市场格局。这正在建立一个可互通的医疗生态系统，将硬体与临床监护平台直接连接起来。製造商正逐步将高精度资料传输模组整合到患者监护仪和人工呼吸器中，从而实现对呼吸动态的持续远端监测，显着改善医院工作流程并提升病患安全。皇家飞利浦最新的财务数据显示，其互联医疗业务板块2023年的可比收入增长了5%，这主要得益于其医院病患监测产品组合的两位数增长，也印证了其对网络解决方案的战略重点。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球呼吸护理设备市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 产品类别（治疗设备、监控设备、耗材、配件）
  • 依最终使用者（医院/诊所、门诊手术中心、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美呼吸护理设备市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲呼吸护理设备市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区呼吸照护设备市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲呼吸护理设备市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲呼吸护理设备市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章 全球呼吸照护设备市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Dragerwerk AG & Co. KGaA
• Fisher & Paykel Healthcare Limited
• General Electric Company
• Getinge AB
• Inogen, Inc.
• Masimo
• Medtronic
• Koninklijke Philips NV
• ResMed
• VYAIRE

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Respiratory Care Devices Market is projected to expand significantly, rising from USD 18.92 Billion in 2025 to USD 31.07 Billion by 2031, reflecting a compound annual growth rate of 8.62%. This sector encompasses a wide variety of medical equipment utilized for the diagnosis, monitoring, and treatment of cardiopulmonary disorders, with growth primarily fueled by the increasing global incidence of chronic ailments like asthma and chronic obstructive pulmonary disease. Highlighting the impact of environmental factors, the American Lung Association reported in 2024 that nearly 131 million individuals in the United States resided in areas with hazardous air pollution levels, a condition that worsens lung health and sustains the demand for supplemental oxygen and bronchial hygiene tools.

Despite these positive indicators, the market faces a substantial obstacle due to the high acquisition costs associated with sophisticated ventilation and monitoring equipment. Financial limitations within healthcare systems, particularly in developing nations, often hinder the procurement of these vital devices, thereby restricting patient access to essential care. Furthermore, inconsistent reimbursement frameworks for home-based respiratory services introduce financial unpredictability for both healthcare providers and patients, which can delay the widespread adoption of newer therapeutic methods in regions that are sensitive to price fluctuations.

Market Driver

The surging global prevalence of chronic and infectious respiratory illnesses acts as the primary force accelerating the respiratory care devices market. As pollution and airborne pathogens increasingly compromise lung function worldwide, the demand for reliable diagnostic and therapeutic interventions has intensified, especially for conditions requiring prolonged management. This growing disease burden necessitates that healthcare systems augment their inventories of airway management and oxygen therapy equipment to accommodate the rising number of patients requiring critical support, a need underscored by the World Health Organization's 'Global Tuberculosis Report 2024', which estimated that 10.8 million people fell ill with tuberculosis globally in 2023.

In parallel, there is a marked increase in the demand for remote monitoring and home-based respiratory care, which is fundamentally transforming service delivery. Patients and medical providers are gravitating towards smart, portable devices that enable continuous therapy outside of conventional hospital environments, aiming to lower readmission rates and improve quality of life. This shift towards residential treatment is reflected in the financial results of key industry players; Fisher & Paykel Healthcare reported an 18% revenue increase in their Homecare product group in 2024, while ResMed saw a 9% rise in quarterly revenue, confirming the continued investment in advanced, home-focused respiratory care ecosystems.

Market Challenge

A major impediment to the growth of the global respiratory care devices market is the steep cost associated with acquiring advanced monitoring and ventilation technologies. This economic barrier significantly curtails the ability to procure necessary medical equipment, particularly in developing countries where healthcare infrastructure is often underfunded. Consequently, the inability to purchase these critical devices restricts patient access to essential treatments and decelerates the wider adoption of innovative therapeutic solutions in regions that are highly sensitive to pricing pressures.

Additionally, the immense economic strain caused by respiratory diseases places further pressure on healthcare budgets, leaving few resources available for investing in expensive equipment upgrades. According to the European Respiratory Society, the annual societal cost of lung health in the European Union hit €422 billion in 2024, a massive financial burden that generates uncertainty for providers and complicates reimbursement structures. As a result, market expansion is often stalled in key territories as healthcare systems struggle to balance the escalating costs of disease management with the necessity for advanced technological solutions.

Market Trends

The application of Artificial Intelligence and Machine Learning for predictive diagnostics is gaining significant traction within the respiratory sector, driven by major capital investments in technologies that automate the analysis of lung imaging and respiratory biometrics. This trend involves the creation of advanced algorithms capable of detecting early-stage malignancies and tuberculosis with greater accuracy than manual methods, thereby attracting strong investor confidence in their potential to improve clinical outcomes. Demonstrating this financial momentum, Qure.ai secured $65 million in Series D funding in September 2024 to expedite the expansion of its AI-driven lung health solutions into the US market, confirming the high industry value placed on automated diagnostic capabilities.

Simultaneously, the integration of IoT and smart connectivity into respiratory devices is transforming the market by establishing interoperable care ecosystems that link hardware directly with clinical oversight platforms. Manufacturers are progressively embedding high-fidelity data transmission modules into patient monitors and ventilators to enable continuous, remote observation of respiratory mechanics, which significantly enhances hospital workflow and patient safety. This strategic emphasis on networked solutions is supported by recent financial data from Royal Philips, which reported a 5% increase in comparable sales for its Connected Care segment in 2023, driven by double-digit growth in its hospital patient monitoring portfolio.

Key Market Players

• Dragerwerk AG & Co. KGaA
• Fisher & Paykel Healthcare Limited
• General Electric Company
• Getinge AB
• Inogen, Inc.
• Masimo
• Medtronic
• Koninklijke Philips N.V.
• ResMed
• VYAIRE

Report Scope

In this report, the Global Respiratory Care Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Respiratory Care Devices Market, By Product

• Therapeutic Devices
• Monitoring Devices
• Consumables
• Accessories

Respiratory Care Devices Market, By End User

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

Respiratory Care Devices Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Respiratory Care Devices Market.

Available Customizations:

Global Respiratory Care Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Respiratory Care Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Therapeutic Devices, Monitoring Devices, Consumables, Accessories)
  • 5.2.2. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Respiratory Care Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Respiratory Care Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Respiratory Care Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Respiratory Care Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By End User

7. Europe Respiratory Care Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Respiratory Care Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By End User
  • 7.3.2. France Respiratory Care Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By End User
  • 7.3.3. United Kingdom Respiratory Care Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Respiratory Care Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Respiratory Care Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By End User

8. Asia Pacific Respiratory Care Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Respiratory Care Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By End User
  • 8.3.2. India Respiratory Care Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Respiratory Care Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Respiratory Care Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Respiratory Care Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By End User

9. Middle East & Africa Respiratory Care Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Respiratory Care Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By End User
  • 9.3.2. UAE Respiratory Care Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By End User
  • 9.3.3. South Africa Respiratory Care Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By End User

10. South America Respiratory Care Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Respiratory Care Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By End User
  • 10.3.2. Colombia Respiratory Care Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By End User
  • 10.3.3. Argentina Respiratory Care Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Respiratory Care Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Dragerwerk AG & Co. KGaA
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Fisher & Paykel Healthcare Limited
• 15.3. General Electric Company
• 15.4. Getinge AB
• 15.5. Inogen, Inc.
• 15.6. Masimo
• 15.7. Medtronic
• 15.8. Koninklijke Philips N.V.
• 15.9. ResMed
• 15.10. VYAIRE

16. Strategic Recommendations

17. About Us & Disclaimer